Download Content

Nanofitin-Antibody fusion as a novel multispecific platform: providing extra specificities while maintaining developability

Please enter your details into the form below to access the Webinar on Nanofitin-Antibody Fusion as a Novel Multispecific Platform hosted with Mathieu Cinier, Scientific Director, Affilogic

We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.

Contact Us:

Copyright Oxford Global Marketing Limited. All rights reserved.